Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie
Klinikum / Johannes Gutenberg-Universität Mainz
Hervas, Amaia; Huss, Michael; Johnson, Mats et al.
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trialEUROPEAN NEUROPSYCHOPHARMACOLOGY. Bd. 24. H. 12. 2014 S. 1861-1872
Reutter, Heiko; Draaken, Markus; Pennimpede, Tracie et al.
Genome-wide association study and mouse expression data identify a highly conserved 32 kb intergenic region between WNT3 and WNT9b as possible susceptibility locus for isolated classic exstrophy of the bladderHUMAN MOLECULAR GENETICS. Bd. 23. H. 20. 2014 S. 5536-5544
Hervas, A.; Huss, M.; Johnson, M. et al.
GUANFACINE XR (GXR) FOR CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): PHASE 3, BLIND, MULTICENTER, PLACEBO- AND ACTIVE-REFERENCE STUDYEUROPEAN PSYCHIATRY. Bd. 29. 2014
Zeidler, Claudia; Woelfle, Joachim; Draaken, Markus et al.
Heterozygous FGF8 Mutations in Patients Presenting Cryptorchidism and Multiple VATER/VACTERL Features without Limb AnomaliesBIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY. Bd. 100. H. 10. 2014 S. 750-759
Ginsberg, Y.; Arngrim, T.; Philipsen, A. et al.
Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core StudyCNS DRUGS. Bd. 28. H. 10. 2014 S. 951-962
Newcorn, J.; Harpin, V.; Huss, M. et al.
LONG-TERM MAINTENANCE OF EFFICACY OF EXTENDED-RELEASE GUANFACINE HYDROCHLORIDE (GXR) IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, PHASE 3 RANDOMIZED WITHDRAWAL STUDYEUROPEAN PSYCHIATRY. Bd. 29. 2014
Ginsberg, Y.; Tvedten, T.; Arngrim, T. et al.
LONG-TERM SAFETY OF METHYLPHENIDATE HYDROCHLORIDE MODIFIED RELEASE (MPH-LA) IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTSEUROPEAN PSYCHIATRY. Bd. 29. 2014
Ginsberg, Y.; Tvedten, T.; Arngrim, T. et al.
METHYLPHENIDATE HYDROCHLORIDE MODIFIED RELEASE (MPH-LA) MAINTAINED EFFICACY OVER LONG-TERM IN THE TREATMENT OF ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)EUROPEAN PSYCHIATRY. Bd. 29. 2014
Huss, Michael; Ginsberg, Ylva; Tvedten, Torbjorn et al.
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled TrialADVANCES IN THERAPY. Bd. 31. H. 1. 2014 S. 44-65
Wijers, Charlotte H. W.; de Blaauw, Ivo; Zwink, Nadine et al.
No Major Role for Periconceptional Folic Acid Use and Its Interaction with the MTHFR C677T Polymorphism in the Etiology of Congenital Anorectal MalformationsBIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY. Bd. 100. H. 6. 2014 S. 483-492